For instance, Kuo et al. reported that mEHT increased efficiency by combining with the HSP inhibitors nano-curcumin and resveratrol in an in vivo CT26/BALB/c animal tumor model caused by decreased HSP70 expression and the infiltration of immune cells (CD3+ T-cells and F4/80+ macrophages) into tumors receiving this treatment [229]. The gene discussed is HSP90B2P; the disease is neoplasm.